Powder: -20°C for 3 years | In solvent: -80°C for 1 year
ENT-C225 is a potent TrkB neurotrophin receptor (TrkBR) activator with neuroprotective activity for the study of Alzheimer's disease and Parkinson's disease.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 195.00 | |
5 mg | In stock | $ 483.00 | |
10 mg | In stock | $ 692.00 | |
25 mg | In stock | $ 1,080.00 | |
50 mg | In stock | $ 1,490.00 |
Description | ENT-C225 is a potent TrkB neurotrophin receptor (TrkBR) activator with neuroprotective activity for the study of Alzheimer's disease and Parkinson's disease. |
In vitro | ENT-C225 demonstrates superior physicochemical properties, higher potency in activating TrkBR, and promising neuroprotective characteristics. Treatment with ENT-C225 at a concentration of 1 µM for 20 minutes significantly promotes phosphorylation of the TrkB receptor in NIH-3T3 TrkB cells and primary astrocytes[1]. |
Molecular Weight | 488.62 |
Formula | C26H40N4O5 |
CAS No. | 2919962-53-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
ENT-C225 2919962-53-9 Tyrosine Kinase/Adaptors Trk receptor inhibitor inhibit